Physician

Lori A Lavelle, DO

According to 2025 Medicare claims, Lori Lavelle, DO (NPI: 1639162241) practices rheumatology in the Altoona, PA market, with the plurality of this provider's patient population coming from Blair, PA. This provider's primary affiliated billing organization is ALAN J KIVITZ MD PC (NPI: 1770682544; TIN: 251531976) and primary practice location at 16635-8445. Lavelle is affiliated with the ACO West Virginia (ACO ID: A3563) and AdvantagePoint Health Alliance - Laurel Highlands, LLC (ACO ID: A4657), participating under the MSSP model.

Lavelle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 505 traditional Medicare patients, billed 81,519 HCPCS/CPT codes, and received $879,256 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,657 prescription claims across 981 beneficiaries totaling $2,416,677 in drug costs, led by Rinvoq (Upadacitinib). 2021 DME data shows 12 claims. Open Payments data shows 207 records totaling $2,723. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $239,991 to $879,256. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,405 to $2,135.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	456	25,179	$239,991
2016	457	26,899	$329,566
2017	472	56,064	$563,690
2018	502	60,489	$676,673
2019	578	83,749	$892,712
2020	533	80,876	$882,199
2021	613	78,343	$957,070
2022	527	73,524	$776,382
2023	511	80,415	$697,992
2024	505	81,519	$879,256

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	700	7,510	$2,001,280
2016	762	7,328	$2,826,070
2017	773	7,374	$2,241,926
2018	814	7,420	$2,507,360
2019	855	7,287	$2,734,458
2020	854	6,352	$2,435,049
2021	871	5,715	$2,269,015
2022	916	6,109	$2,457,321
2023	937	5,808	$2,973,137
2024	981	5,657	$2,416,677

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$232
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	22	$1,332
2020	N/R	N/R	N/R
2021	N/R	12	$729
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	420	734	$85
36415	Insertion of needle into vein for collection of blood sample	302	470	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	295	468	$7
86140	Measurement c-reactive protein for detection of infection or inflammation	251	389	$5
85651	Red blood cell sedimentation rate, to detect inflammation, non-automated	279	444	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rinvoq	Upadacitinib	70	2,400	$501,689
Enbrel Sureclick	Etanercept	48	1,764	$446,259
Humira(Cf) Pen	Adalimumab	40	1,234	$299,536
Xeljanz Xr	Tofacitinib Citrate	34	1,020	$190,321
Enbrel	Etanercept	13	364	$95,385

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	207	$2,723	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Lori A. Lavelle, DO?

Tedicare shows public-source Medicare data for Lori A. Lavelle, DO (NPI 1639162241), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lori A. Lavelle, DO have ACO affiliation data?

Lori A. Lavelle, DO is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and AdvantagePoint Health Alliance - Laurel Highlands, LLC (MSSP, ACO ID A4657).

What billing organization is linked to Lori A. Lavelle, DO?

Lori A. Lavelle, DO is linked to ALAN J KIVITZ MD PC (billing NPI 1770682544) in the available physician profile data.

Does Lori A. Lavelle, DO have Open Payments data?

Lori A. Lavelle, DO has 207 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.